Who Owns Quipt Home Medical Company?

Who owns Quipt Home Medical?

Quipt Home Medical shifted from a regional DME provider to a NASDAQ-listed mid-cap focused on home respiratory care after rebranding from Patient Home Monitoring. Its ownership mix of institutions, retail holders, and insiders drives an aggressive acquisition-led growth strategy.

By early 2025 Quipt served over 290,000 patients across 25+ states with revenues near $260 million; institutional investors and management stakes shape strategy and accountability, while retailholders add liquidity and public scrutiny. See Quipt Home Medical Porter's Five Forces Analysis for product context.

Founders and Early Ownership of Quipt Home Medical trace back to Patient Home Monitoring (PHM) in the early 1990s, when a founding team launched home-based diagnostic testing and listed on the TSX Venture Exchange amid fragmented retail ownership and limited institutional anchors.

Early founding

Patient Home Monitoring (PHM) was created in the early 1990s to commercialize home diagnostic testing, forming the base of what became Quipt Home Medical.

TSX Venture era

During its TSX Venture listing the cap table was highly fragmented with high-volume retail trading and minimal institutional oversight.

Founders' control

Founding management and private placement investors maintained majority voting control under standard Canadian vesting schedules.

Leadership transitions

Multiple leadership changes prompted exits of original founders and shifts in the company’s ownership and governance structure.

Early 2010s financing

Small-cap Canadian backers provided bridge financing for initial acquisitions, but lack of a long-term institutional anchor increased volatility.

Shift to institutional ownership

Under CEO Greg Crawford and CFO Hardik Mehta ownership was redistributed toward institutional investors, emphasizing operational efficiency over speculative growth.

Ownership history shows a move from fragmented retail stakes to a more concentrated, institutionally backed cap table, aligning with strategic acquisitions and management-led recapitalizations.

Key points on founders and early ownership

Founding, control shifts, and financial backers shaped the early corporate structure and later ownership of Quipt Home Medical.

• Founded as Patient Home Monitoring (PHM) in early 1990s; pivoted into Quipt Home Medical ownership history.
• TSX Venture listing produced fragmented retail-heavy ownership and limited institutional participation.
• Founders and private placement investors initially held majority voting control under typical Canadian vesting rules.
• Leadership change to CEO Greg Crawford and CFO Hardik Mehta led to equity redistribution favoring institutional investors and operational focus.

For further context on strategy and ownership transitions see Growth Strategy of Quipt Home Medical.

Complete Quipt Home Medical Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

Key events reshaping Quipt Home Medical ownership include its 2021 NASDAQ relist and rebrand to Quipt, a shift to institutional shareholders, and post-2020 acquisition-fueled capital raises that diluted early private investors.

Institutionalization followed the NASDAQ debut and name change; access to over $100 million in combined credit facilities and equity since 2020 financed more than 15 acquisitions, altering the Quipt Home Medical corporate structure and investor mix.

Ownership Snapshot — Early 2025

Quipt Home Medical ownership now reflects a mix of institutional capital, management stakes, and diluted early venture holders.

• Institutional stake rose to ~34% from under 10% during the PHM era
• Top named holder: Royce and Associates at 7.2%
• Insiders retain ~6.5%, aligning leadership with EBITDA-margin objectives
• M&A-driven capital raises shifted ownership toward long-term institutional investors

For context on competitive positioning and ownership implications, see Competitors Landscape of Quipt Home Medical

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

Quipt Home Medical’s Board of Directors follows a one-share-one-vote model with Greg Crawford serving as Chairman and CEO; the board combines industry veterans and financial experts to oversee strategy, audit and compensation decisions.

The governance framework prioritizes proportional voting rights and shareholder accountability, attracting institutional investors focused on transparent corporate structure and ESG alignment.

Board composition and voting power

The top ten institutional holders and executive management collectively control nearly 45% of voting power, supporting the board’s long-term consolidation strategy while limiting takeover risk.

• One-share-one-vote corporate structure ensures proportional voting aligned with economic interest
• Board chaired by Greg Crawford, combining CEO operational control with board leadership
• Independent oversight via audit and compensation committees led by Brian Shidlowsky and Mark G. Herry
• Active shareholder engagement, including NCIB renewals, attracts ESG-conscious investors

For context on the company’s guiding principles and management approach, see Mission, Vision & Core Values of Quipt Home Medical

Quipt Home Medical Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

Recent ownership trends show Quipt Home Medical moving toward concentrated institutional ownership through aggressive share buybacks and targeted investor exits, while preparing for potential corporate-scale transactions as revenues approach projected $288,000,000 for 2025.

Management commentary at the 2025 AGM referenced strategic options including up-listing or merger pathways, reflecting a corporate structure strategy responsive to a stabilized market cap range of $150,000,000–$200,000,000 and supply-chain normalization in the sleep apnea market.

Share Buyback Activity

NCIB executions in late 2024 and early 2025 removed hundreds of thousands of shares from circulation, increasing per-share metrics and ownership concentration among institutional holders.

Investor Base Evolution

Early-stage venture exits and growing allocations from specialized healthcare funds have reduced retail presence and stabilized the shareholder mix toward long-term institutional investors.

Potential Strategic Outcomes

Analyst commentary and AGM remarks point to possible up-listing or strategic merger if valuation convergence with peers like AdaptHealth continues, increasing likelihood of a corporate parent or PE consortium acquiring control.

Related Reading

Context on Quipt Home Medical ownership and target demographics is available in this focused piece: Target Market of Quipt Home Medical

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE